US Patent Issued to Dana-Farber Cancer Institute on Feb. 3 for "Inhibitors of cyclin-dependent kinases" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. RE50,776, issued on Feb. 3, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Inhibitors of cyclin-dependent kinases" was invented by Nathanael S. Gray (Boston), Tinghu Zhang (Brookline, Mass.) and Nicholas Paul Kwiatkowski (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides novel compounds of Formula (I), (II), or (III), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating and/or p...